UK pharma major GSK (LSE: GSK) has published results from its Phase III MATINEE trial evaluating Nucala (mepolizumab) in ...

UK regulators are set to review a proposed label update for Eisai (TYO: 4523) and Biogen’s (Nasdaq: BIIB) Alzheimer’s drug ...

The Russian drugmaker Akrikhin has filed a lawsuit against UK pharma major AstraZeneca (LSE: AZN) to the Moscow Intellectual ...

Shanghai-based biotech Shijian Bio has signed an exclusive option agreement with US firm ConjugateBio to license its EZWi-Fit ...

US pharma giant Merck & Co has started building a $1 billion, 470,000-square-foot biologics center of excellence in ...

Chicago-based drugmaker AbbVie has announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), ...

US biotech Transneural Therapeutics has named industry veteran Mark Demitrack as its chief research and development officer, ...

US biotech firm Stealth BioTherapeutics (OTCQB: MITO) is facing renewed uncertainty after the American medicines regulator ...

Danish drugmaker Novo Nordisk has announced that it is expanding patient access to Wegovy (semaglutide) injection 2.4 mg in ...

Regulus Therapeutics (Nasdaq: RGLS) saw its shares leap 133% to $7.84 in pre-market activity this morning, on the news it has ...

Swiss generics and biosimilars major Sandoz (SIX: SDZ) has signed a global collaboration with Shanghai Henlius Biotech (HKEX: ...

The US Food and Drug Administration (FDA) has approved Zevaskyn (prademagene zamikeracel) gene-modified cellular sheets, also ...